Effect of neoadjuvant chemotherapy on outcomes of immediate free autologous breast reconstruction

European Journal of Surgical Oncology

Volumn 39, Issue 5, 2013, Pages 430-436

  Schaverien, M V ^a   Munnoch, D A ^a  

^a NINEWELLS HOSPITAL   (United Kingdom)

Author keywords

Complications; Immediate free flap breast reconstruction; Neoadjuvant chemotherapy; Outcomes

Indexed keywords

CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; EPIRUBICIN; FLUOROURACIL; HEMOGLOBIN; PACLITAXEL;

ADJUVANT CHEMOTHERAPY; ADULT; ANASTOMOSIS; ARTICLE; BLOOD TRANSFUSION; BREAST CANCER; BREAST RECONSTRUCTION; CANCER RADIOTHERAPY; CONTROLLED STUDY; DONOR SITE; FAT NECROSIS; FEMALE; FREE TISSUE GRAFT; GRAFT FAILURE; HEMATOMA; HOSPITAL ACQUIRED PNEUMONIA; HUMAN; INFECTION; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MASTECTOMY; OBESITY; OUTCOME ASSESSMENT; POSTOPERATIVE COMPLICATION; PREOPERATIVE EVALUATION; PREOPERATIVE PERIOD; PRIORITY JOURNAL; SEROMA; SKIN NECROSIS; SMOKING; THERAPY DELAY;

ADULT; AGED; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; CHI-SQUARE DISTRIBUTION; ENGLAND; FEMALE; HUMANS; MAMMAPLASTY; MIDDLE AGED; NEOADJUVANT THERAPY; OBESITY; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; RADIOTHERAPY, ADJUVANT; REOPERATION; RISK FACTORS; SMOKING; STATISTICS, NONPARAMETRIC; SURGICAL FLAPS; TRANSPLANTATION, AUTOLOGOUS;

EID: 84876415488     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2013.02.015     Document Type: Article

References (33)

1. J. Mathew, K.S. Asgeirsson, K.L. Cheung, S. Chan, A. Dahda, and J.F. Robertson Neoadjuvant chemotherapy for locally advanced breast cancer: a review of the literature and future directions Eur J Surg Oncol 35 2009 113
2. S.V. Liu, L. Melstrom, K. Yao, C.A. Russell, and S.F. Sener Neoadjuvant therapy for breast cancer J Surg Oncol 101 2010 283
3. A.U. Buzdar Preoperative chemotherapy treatment of breast cancer-a review Cancer 110 2007 2394
4. B. Fisher, J. Bryant, and N. Wolmark Effect of preoperative chemotherapy on the outcome of women with operable breast cancer J Surg Oncol 16 1998 2672
5. B. Fisher, A. Brown, and E. Mamounas Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18 J Surg Oncol 15 1997 2479
6. T.A. Buchholz, C.D. Lehman, and J.R. Harris Statement of the science concerning locoregional treatments after preoperative chemotherapy for breast cancer: a National Cancer Institute conference J Surg Oncol 26 2008 791
7. A. Berruti, D. Generali, and M. Kaufmann International expert consensus on primary systemic therapy in the management of early breast cancer: highlights of the Fourth Symposium on Primary Systemic Therapy in the Management of Operable Breast Cancer, Cremona, Italy (2010) J Natl Cancer Inst Monogr 43 2011 147
8. A. Valachis, D. Mauri, N.P. Polyzos, G. Chlouverakis, D. Mavroudis, and V. Georgoulias Trastuzumab combined to neoadjuvant chemotherapy in patients with HER2-positive breast cancer: a systematic review and meta-analysis Breast 20 2011 485
9. L. Gianni, W. Eiermann, and V. Semiglazov Neoadjuvant chemotherapy with trastuzumab followed by adjuvant trastuzumab versus neoadjuvant chemotherapy alone, in patients with HER2-positive locally advanced breast cancer (the NOAH trial): a randomised controlled superiority trial with a parallel HER2-negative cohort Lancet 375 2010 377
10. X. Kong, M.S. Moran, N. Zhang, B. Haffty, and Q. Yang Meta-analysis confirms achieving pathological complete response after neoadjuvant chemotherapy predicts favourable prognosis for breast cancer patients Eur J Cancer 47 2011 2084
11. D. Mauri, N. Pavlidis, and J.P. Ioannidis Neoadjuvant versus adjuvant systemic treatment in breast cancer: a meta-analysis J Natl Cancer Inst 97 2005 188
12. P. Rastogi, S.J. Anderson, and H.D. Bear Preoperative chemotherapy: updates of National Surgical Adjuvant Breast and Bowel Project protocols B-18 and B-27 J Surg Oncol 26 2008 778
13. Y. Xing, M. Foy, D.D. Cox, H.M. Kuerer, K.K. Hunt, and J.N. Cormier Meta-analysis of sentinel node biopsy after preoperative chemotherapy in patients with breast cancer Br J Surg 93 2006 539
14. J.F. Waljee, and L.A. Newman Neoadjuvant systemic therapy and the surgical management of breast cancer Surg Clin North Am 87 2007 399
15. M. Zweifel-Schlatter, N. Darhouse, P. Roblin, D. Ross, M. Zweifel, and J. Farhadi Immediate microvascular breast reconstruction after neoadjuvant chemotherapy: complication rates and effect on start of adjuvant treatment Ann Surg Oncol 17 2010 2945
16. F.P. Albino, P.F. Koltz, M.N. Ling, and H.N. Langstein Irradiated autologous breast reconstructions: effects of patient factors and treatment variables Plast Reconstr Surg 126 2010 12
17. K. Azzawi, A. Ismail, H. Earl, P. Forouhi, and C.M. Malata Influence of neoadjuvant chemotherapy on outcomes of immediate breast reconstruction Plast Reconstr Surg 126 2010 1
18. B.J. Mehrara, T.D. Santoro, E. Arcilla, J.P. Watson, W.W. Shaw, and A.L. Da Lio Complications after microvascular breast reconstruction: experience with 1195 flaps Plast Reconstr Surg 118 2006 1100
19. J.C. Selber, J.E. Kurichi, S.J. Vega, S.S. Sonnad, and J.M. Serletti Risk factors and complications in free TRAM flap breast reconstruction Ann Plast Surg 56 2006 492
20. M.F. Deutsch, M. Smith, B. Wang, N. Ainsle, and M.A. Schusterman Immediate breast reconstruction with the TRAM flap after neoadjuvant therapy Ann Plast Surg 42 1999 240
21. M.R. Sultan, M.L. Smith, A. Estabrook, F. Schnabel, and D. Singh Immediate breast reconstruction in patients with locally advanced disease Ann Plast Surg 38 1997 345
22. World Health Organisation Obesity and overweight Factsheet No. 311 May 2012 http://www.who.int/mediacentre/factsheets/fs311/en/index.html
23. D.W. Chang, B. Wang, and G.L. Robb Effect of obesity on flap and donor-site complications in free transverse rectus abdominis myocutaneous flap breast reconstruction Plast Reconstr Surg 105 2000 1640
24. D.W. Chang, G.P. Reece, and B. Wang Effect of smoking on complications in patients undergoing free TRAM flap breast reconstruction Plast Reconstr Surg 105 2000 2374
25. B. Leyland-Jones, V. Semiglazov, and M. Pawlicki Maintaining normal hemoglobin levels with epoetin alfa in mainly nonanemic patients with metastatic breast cancer receiving first-line chemotherapy: a survival study J Clin Oncol 23 2005 5960
26. M. Untch, G. von Minckwitz, and G. Konecny PREPARE trial. A randomized phase III trial comparing preoperative, dose-dense, dose-intensified chemotherapy with epirubicin, paclitaxel and CMF versus a standard dosed epirubicin/cyclophosphamide followed by paclitaxel +/- darbepoetin alfa in primary breast cancer-outcome on prognosis Ann Oncol 22 2011 1999
27. T.J. Littlewood, E. Bajetta, and J.W.R. Nortier Effects of epoetin alfa on hematologic parameters and quality of live in cancer patients receiving nonplatinum chemotherapy: results of a randomized, double-blind, placebo-controlled trial J Clin Oncol 19 2001 2865
28. C. Lohrisch, C. Paltiel, and K. Gelmon Impact on survival of time from definitive surgery to initiation of adjuvant chemotherapy for early-stage breast cancer J Clin Oncol 24 2006 4888
29. H.T. Gold, H.T. Do, and A.W. Dick Correlates and effect of suboptimal radiotherapy in women with ductal carcinoma in situ or early invasive breast cancer Cancer 113 2008 3108
30. S. Greenberg, A. Stopeck, and H.S. Rugo Systemic treatment of early breast cancer-a biological perspective J Surg Oncol 103 2011 619
31. H.D. Bear Neoadjuvant chemotherapy for operable breast cancer: individualizing locoregional and systemic therapy Surg Oncol Clin N Am 19 2010 607
32. A.S. Caudle, and K.K. Hunt The neoadjuvant approach in breast cancer treatment: it is not just about chemotherapy anymore Curr Opin Obstet Gynecol 23 2011 31
33. M. Kaufmann, G.N. Hortobagyi, and A. Goldhirsch Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: an update J Clin Oncol 2006 1940 24